The FDA announced today that it has approved the first generic naloxone hydrochloride nasal spray, a life-saving medication that is designed to stop or reverse opioid overdose effects.
The FDA also said that it is planning new steps to prioritize the review of other generic drug applications that treat opioid overdose.
Nearly 400,000 people have died from an opioid overdose between 1999 and 2017, according to the Centers for Disease Control and Prevention. Approximately 130 Americans die every day from overdoses that involve opioids, including prescription medication and street drugs like heroin, which is often laced with fentanyl. Once an overdose occurs, reviving a person to full consciousness can be difficult. Breathing slows down and can even stop, which in turn can lead to death.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.